| Sejla Cejvanovic, ARNP | |
|
905 Franklin St, Waterloo, IA 50703-4407 | |
| (319) 874-3000 | |
| Not Available |
| Full Name | Sejla Cejvanovic |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 905 Franklin St, Waterloo, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023761764 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A167274 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peoples Community Health Clinic, Inc. | 6406746668 | 20 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
True Results, a leading provider of bariatric weight loss solutions, announced it has completed the first non-surgical True Balloon procedure with the ORBERA Intragastric Balloon in Texas.
Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa's president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw's 11th Annual Healthcare Conference.
Patient Advocate Foundation - a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases - today released their annual Patient Data Analysis Report, which documents the scope and complexity of the healthcare finance, access and job retention issues routinely confronted by patients at the national and state-specific level.
› Verified 9 days ago
| Entity Name | Peoples Community Health Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629684709 PECOS PAC ID: 6406746668 Enrollment ID: O20040319000493 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
True Results, a leading provider of bariatric weight loss solutions, announced it has completed the first non-surgical True Balloon procedure with the ORBERA Intragastric Balloon in Texas.
Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa's president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw's 11th Annual Healthcare Conference.
Patient Advocate Foundation - a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases - today released their annual Patient Data Analysis Report, which documents the scope and complexity of the healthcare finance, access and job retention issues routinely confronted by patients at the national and state-specific level.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sejla Cejvanovic, ARNP 1732 Waxwing Way, Waterloo, IA 50701-1207 Ph: (319) 464-2500 | Sejla Cejvanovic, ARNP 905 Franklin St, Waterloo, IA 50703-4407 Ph: (319) 874-3000 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
True Results, a leading provider of bariatric weight loss solutions, announced it has completed the first non-surgical True Balloon procedure with the ORBERA Intragastric Balloon in Texas.
Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa's president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw's 11th Annual Healthcare Conference.
Patient Advocate Foundation - a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases - today released their annual Patient Data Analysis Report, which documents the scope and complexity of the healthcare finance, access and job retention issues routinely confronted by patients at the national and state-specific level.
› Verified 9 days ago
Kurtis Alan Lucas, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 Kimball Ave Ste 101, Waterloo, IA 50702 Phone: 319-272-2112 Fax: 319-272-2107 | |
Mark J Louviere, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 212 W Dale St, Waterloo, IA 50703 Phone: 319-235-3568 Fax: 319-235-5013 | |
Dr. Robert L Friedman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2055 Kimball Ave, Suite 101, Waterloo, IA 50702 Phone: 319-272-2112 Fax: 319-272-2107 | |
Manpreet Singh Gill, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2055 Kimball Ave, Suite 101, Waterloo, IA 50702 Phone: 319-272-2112 Fax: 319-272-2107 | |
Emily Rose Pursley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Medical Arts Bldg., 2055 Kimball Ave. Suite 101, Waterloo, IA 50702 Phone: 319-272-2112 | |
Brett D Van Kley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 Kimball Ave, Suite 101, Waterloo, IA 50702 Phone: 319-272-2112 Fax: 319-272-2107 |